Innovative Medicines Initative 2 (IMI2) – Call 13 is Open

Innovative Medicines Initiative (IMI) has launched Call 13 for proposals covering diabetes, antimicrobial resistance, neurodegenerative diseases, cancer, and medicines safety during pregnancy and breastfeeding, to name just a few. The total budget of the Call is EUR 223 million, around half of which comes from the EU’s Horizon 2020 programme, and half of which comes from EFPIA companies and IMI Associated Partners.

Further Informations and the full list of topics:

Innovative Medicines Initative 2 (IMI2) – Call 13 Webinars

IMI will hold webinars on IMI2 – Call 13 from 27 November 2017 to 15 December 2017 inclusive.

All webinars on the Call topics will feature a presentation by the EFPIA topic coordinator and time for questions and answers. The webinars represent an excellent opportunity to learn more about the Call topics, interact directly with the topic coordinators, and get in touch with potential project partners.

More Information